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What is already known about this topic? 70 wordsSkin cancer is the most common cancer in humans.Incidence of skin cancer is high compared to other malignancies and isincreasing.Few studies have directly investigated the psychosocial effects of keratinocytecarcinoma and its treatmentA previous review included only two studies that looked at the needs andexperiences of skin cancer patients
What does the study add?12 additional studies were identified.These focused primarily on melanoma.
Diagnosis of any type of skin cancer can be distressing and its experience isdependent on its type and severity.Patients need emotional support and information that should be tailored to thestage of their particular skin cancer journeyFor all skin cancer patients, their experience continues post-treatment, with on-going needs for information about risk management and skin cancer detection.
Summary (Abstract) 250 words
BackgroundSkin cancer incidence is increasing worldwide. This is an update of a previousreview published in 2010 that identified only two studies and found that theneeds and experiences of individuals with skin cancer were under-researched.
ObjectivesTo undertake a qualitative systematic review of the needs and experiences ofpeople with a diagnosis of skin cancer.
MethodsAs an update of a previous review, the following databases were searched from2010 to 30/11/15: CINAHL PsycINFO, MEDLINE and EMBASE. Themethodological quality of the studies was assessed using the Joanna BriggsInstitute (JBI) Qualitative Assessment Review Instrument (QARI). The qualitativeresearch findings were synthesised using a pragmatic meta-aggregativeapproach.
ResultsFourteen studies (16 papers) were included. Only three studies includedkeratinocyte carcinoma patients. 15 categories were identified and theseresulted in four overarching synthesised findings (SFs) from diagnosis (SF1)through treatment (SF2) and follow up (SF3), and then a fourth SF (SF4) thataddressed patients’ satisfaction with their care and their relationship with healthprofessionals.
ConclusionsDespite the fact that keratinocyte carcinoma and melanoma patients can havevery different prognosis, they also share similar needs and concerns especiallyaround the time of diagnosis and follow up/surveillance for new lesions. Healthprofessionals working with skin cancer patients need to understand theirpsychosocial concerns, and their information needs in order to design servicesappropriately. Future studies need to consider keratinocyte carcinoma patientsas well as melanoma patients.
IntroductionSkin cancer is the most common cancer in humans and the incidence isincreasing worldwide 1. There are two main types of skin cancer: melanoma andkeratinocyte carcinoma. Keratinocyte carcinoma makes up approximately 97%of skin cancers which are either basal cell carcinomas, or squamous cellcarcinomas, together with some rarer types. Currently, between 2-3 millionkeratinocyte carcinomas and 132,000 melanoma skin cancers occur globallyeach year and one in every three cancers diagnosed is a skin cancer [WHO 2014].Skin cancer affects people from all communities and age groups. Althoughkeratinocyte carcinoma is mostly seen in the over 50’s, increasingly it is beingseen in younger people 2, 3, 4, 5. The large increase in skin cancer incidence andthe fact that keratinocyte carcinoma comes with high rates of recurrence andsubsequent primaries 6 presents a significant challenge for all health caresystems.Patient needs and preferences comprise a core component of evidence-basedmedicine 7, yet, the support needs and experiences of skin cancer patients havereceived limited in-depth attention. This is despite a long standing recognitionthat additional research in this area is required (Improving outcomes for peoplewith skin cancer tumours including melanoma, NICE 2006). Qualitative researchis ideally suited to provide an in-depth picture of skin cancer patient needs andexperiences, but, until fairly recently, most empirical research has beenquantitative in nature 8, 9 and has focused primarily upon melanoma. In 2011,one of the authors of this paper [FBH] published a qualitative systematic reviewand found only two studies that had examined the needs and experiences ofpeople with skin cancer 10. Qualitative systematic reviews have an important roleto play in terms of informing healthcare professionals about the meaningfulness,feasibility and acceptability of healthcare interventions 11. Recently there hasbeen increased interest in conducting qualitative research in dermatology 12 and,therefore, an update of the previous review is timely in order to inform practiceand enhance the patient experience of having a skin cancer.
Material and MethodsThis review adheres to the ENTREQ guidelines 13 and follows the Joanna BriggsInstitute (JBI) methodology for qualitative systematic review 14. This is an updateof a previous review10. The review considered adults with a diagnosis of eitherkeratinocyte carcinoma or melanoma skin cancer in any setting. The phenomenaof interest were the needs and experiences of adults following a diagnosis of skincancer. All qualitative studies (including, but not limited to ethnography,phenomenology, and grounded theory studies) that met the inclusion criteriawere considered. Qualitative elements of mixed method studies were alsoincluded if the qualitative data were presented separately within the publication.The search strategy was designed to be thorough and exhaustive and there wasno restriction on language. All relevant studies were considered irrespective ofdate of publication. Relevant key words appropriate to the review objectiveswere identified following consultation with information specialists. Thefollowing databases were searched from 2010 to 30/11/15: CINAHL PsycINFO,MEDLINE and EMBASE. An example of the search strategy for Medline on Ovid is
given in Table 7. As per current methodological recommendations 15, this wasdesigned to be sensitive rather than specific. The initial search results wereexported to EndNote and duplicates removed automatically. Manual entry ofstudies identified from hand searching of reference lists of studies were enteredinto EndNote separately.The titles and abstracts identified from the search were all independentlyassessed against the inclusion/exclusion criteria by two reviewers and therewere no disagreements between the two reviewers. Full text papers wereobtained of relevant studies and again assessed. There was only one paper whichthe two reviewers disagreed with and this was resolved by involving a thirdreviewer. Studies meeting the inclusion criteria were then independentlyassessed by two reviewers for methodological quality using the JBI QualitativeAssessment and Review Instrument (JBI-QARI) 16. There were no disagreementsand therefore no need to involve a third reviewer.Data extraction utilised a standardised JBI-QARI tool. Two reviewers read eachpaper several times to gain an overall understanding of the key findings and toset them in context. One reviewer then extracted the findings from includedstudies, variously reported as themes, metaphors or categories. Where possible,each extracted finding was supported by a verbatim quote from a researchparticipant to illustrate its meaning. Where this was not possible, the author’snarrative was extracted. All findings were assigned a level of credibility(unequivocal, credible and unsupported). Levels were assigned depending on theextent to which supporting quotes, detail and relevant context were availableand lent weight to the finding’s credibility, as per JBI guidelines [JBI handbook]:
Unequivocal: Findings were accompanied by illustrations that were beyondreasonable doubt and therefore not open to challenge.
Credible: Findings were accompanied by illustrations that lacked a clearassociation and were therefore open to challenge.
Unsupported: Findings not supported by data.Two reviewers independently reviewed the extracted findings and the assignedlevels of credibility and reached agreement that they were appropriate for eachpaper. There were no disagreements regarding level of credibility.The findings were analyzed using JBI’s pragmatic meta-aggregative approach 17.Findings from across the studies were reviewed and grouped together based onsimilarity in concepts/meanings. Categorization involved the aggregation of thefindings to generate a set of categories that represent common meanings. Thequality of the findings was taken into account by considering their relativeimportance in shaping the core constructs of the category. Only findings ratedunequivocal [U] or credible [C] were used to develop the meta-synthesis (Table4). Categories were then compared, contrasted and synthesized further toproduce a set of synthesized findings, defined as an “overarching description of agroup of categorized findings that allow for the generation of recommendationsfor practice” 18. The meta-synthesis process was led by one reviewer. This was an
iterative process, involving review of the findings/categories/synthesizedfindings, going back to the original papers for clarification where necessary, anddiscussion with the whole team until agreement was reached. The ConQual toolwas used to establish confidence in the synthesised findings 19.
ResultsA total of 317 studies were identified (300 from the database searches and as iscommonly reported in qualitative reviews 20, an additional 17 from references ofstudies). A total of 54 duplicates were automatically removed from the 300references. After reviewing the titles and abstracts of 263 studies, the full text of23 studies was reviewed of which 16 studies (14 separate research studies)were included. (Figure 1). The characteristics of the included studies can befound in table 1.Nine studies were conducted in the UK 21, 22, 23, 24, 25, 26, 27, 28 29, three in the USA30, 31 32 and two 33, 34 35 in Australia.Only three studies included keratinocyte carcinoma 21, 22 32. Two studiesincluded melanoma that had relapsed 27 25, two studies included stage I-IIImelanoma 31, 28 and one study included stage III melanoma 35. In two studies, thestage of melanoma was unknown 26, 24. One study looked at intra-family riskcommunication 30, one study included views on a GP led follow up clinic 23 andone study looked at patient satisfaction with follow up care 33The overall quality of the studies was good (Table 2), however only two studies25 26 located the research culturally or theoretically and only one 26 reported theinfluence of the researcher on the research, indicating poor reflexivity overall forthe included studies.
Main findings of the reviewThere were 153 findings, which were either unequivocal or credible. Thesefindings were aggregated into 15 categories. The 15 categories were then meta-aggregated into four synthesized findings. See Table 3 for a summary of themeta-synthesis and Table 4 (supplementary files) for a full version. Key conceptswithin their constituent categories are illustrated using representative textualexcerpts from selected findings (Table 5). The synthesised findings emergedfrom the data, and clustered around the natural time points used by the studiesto collect data and also from the representation of study participants.
Synthesised finding 1: The time of diagnosisDiagnosis is a time of shock and distress, where patients have significant supportand information needs irrespective of the type of skin cancer. For many patients,this diagnosis can come as a severe shock, especially for those who believe theirsymptoms are relatively mild and therefore nothing to worry about.Patients particularly remembered the use of the term ‘cancer’ as causing asignificant shock.
…the consultant just had a look at it and said, ‘I think it’s a … ‘and I couldn’t even remember
the term after I got out of the hospital, but he said ‘I think it’s a basal cell carcinoma’. Now the
only thing I know about the word carcinoma is that it’s linked to cancer. And having shortly
before lost my brother to cancer, I must admit I did initially go into a bit of a flat spin (panic)…
(Winterbottom 2004, p229, BCC)Their immediate distress impacted on their ability to listen and to be responsiveto information given by the clinician at that time of diagnosis. Patients reportednot remembering receiving information at this stage.
I was so upset about the diagnosis that I don’t think much information would have penetrated
because I was too focused on thinking I’ve got cancer because you seem to, I went into a,
like a shocked of my own and switched off I think. (Moore 1996. p60, M)Waiting for biopsy results caused considerable fear and anxiety for manypatients. They felt that they were left to guess about their prognosis and thepossible seriousness of their skin cancer. However once the results were known,many patients felt less anxious, regardless of the result and were able to adjustto their condition.
……but it’s the initial wait, the first, when you see the doctor until you have the first operation,
the waiting and not knowing, you know…that’s the worst part about it, it is the waiting and not
knowing. (Moore 1996. p62, M)Patients also expressed a need for emotional support. In some cases, healthcareproviders gave patients the impression that skin cancer was less important thanother types of cancer and, therefore they underestimated or ignored patients’emotional needs.
….And then, I can’t say I’m feeling down today or whatever, I’m going to [cancer hospital] on
Monday, I feel a bit crap today and all that. But you can’t, I mean, if you knew somebody on
the phone or you were going to [cancer hospital] and you could have half and hour….. But
there’s nothing, you’re just out on a limb really. Even though it’s a cancer, there’s no actual
help type thing (Stamataki 2015, p782, M stage IIIc)
Synthesised finding 2: The time around treatment and immediately
afterwards.For the time around treatment and afterwards, the experience of having skincancer varies depending upon the type, stage and treatment. The impact of a skincancer diagnosis can have significant emotional, physical, social and financialimpact, some of which can be long lasting, and for which patients and theirfamilies may need support. Patients cope with their experiences in a variety ofways.The treatment journey was often depicted as stressful and emotional forpatients, associated with negative experiences such as the complications ofcancer treatments, poor communication with treatment team members, notreceiving adequate information and the uncertainty of not knowing if they wouldget back to how things were before. For some, there was also the need to travellong distances for treatment.
I’d say stress related to the cancer is the most bothersome and biggest issue…there’s an
unknown component whether it’s going to heal or not and whether it’s going to leave physical
scars or not. (Steenrod 2015. p193, non-advanced BCC)
…‘I have struggled to move away from that time in hospital. I found it very difficult. I don’t
think in any way I was prepared for what it would do physically. The seriousness of it and the
debilitating effect of the surgery was far more than I thought it was going to be’ (Stothers
2015. p34-35, M)
In some cases, skin cancer patients expressed negative feelings about an alteredbody image resulting from treatments such as surgery and chemotherapy. Thishad psychological impacts on the patients and often disrupted their socialinteractions.
Uh, I’m tired of having my body cut. I mean, you could say it’s at times mildly depressing
(Steenrod 2015, p194, non-advanced BCC)
: “I was really shocked at what the operation had done. It was really disfiguring ... When
you’re disfigured in any way it takes a toll psychologically. (Tan 2014. p17, M stage III)Having a skin cancer impacted on family and social life and some patientsreported feeling unsupported by their family and/or employer.
…But your managers, you know, like I’d go in and say ‘oh I’m really struggling at the minute,
can you take, I can’t do this, I need a bit of a, some weight taken off me at work’ and they’ll do
it for a short period of time while you’re in distress but then it’s soon back on you isn’t it?
(Stamataki 2015. p784, M stage Ib)Financial costs associated with travel, accommodation and treatment weresometimes an issue. Retaining health care and life insurance was important foryoung melanoma survivors in American studies.
‘I mean and then what do you do if you can’t get health insurance? I’ll have to take a lousy job
that I don’t want to work at so that I’ll have health insurance. Yeah, that’s actually a huge fear
for me.’ (Oliveria 2013 p.111, M stages I to III)Patients developed a range of mechanisms to cope with their cancer, includingavoidance, positive re-framing, sticking to routines, seeking social support andsolace from religious faith.
I have to say I’m a Christian and I believe in healing, and so the whole thing wasn’t too much
of a problem I won’t say I wasn’t concerned, but the faith kept me going and I knew that other
people were praying for me (Winterbottom 2004. P230, M)One study 25 focused particularly on patients who had transitioned from initialdiagnosis of melanoma to nodal relapse. These patients used coping skills learntfrom their initial diagnosis to help with a diagnosis of nodal relapse.
Physically I was aware of the signs of recurrence and psychologically I found it
easier to cope, as opposed to the initial diagnosis which was a major ‘shock’
(Stothers) 2015. P34, nodal relapse of melanoma)
Synthesised finding 3: The time after treatment and the follow up periodSkin cancer survivors and their families may have ongoing support, informationand risk management needs. The survivorship phase can be a period ofliminality, characterised by fear and uncertainty, related to the possible, yet
uncertain, risk of skin cancer recurrence. Patients’ care and information needsduring skin cancer survivorship include the need for being able to identify,prevent and manage further risk for themselves and for the family. Howevermany patients reported a lack of information.Both keratinocyte carcinoma and melanoma patients described an ongoing senseof uncertainty and fear (being in limbo) associated with the possibility ofrecurrence of the skin cancer. This fear was exacerbated by inadequateknowledge about risks of recurrence and about when/how to seek help.
Well, it’s just that, you know, I just hope that it’s all gone and that it’s not going to flare up
again. I mean, I'm touching wood, I don’t think it will do because I don’t think it was that sort of
thing, but there's bound to be doubts, small doubts, you know, even though people do try and
reassure you. But hopefully everything will be okay. (Bath-Hextall 2013. p7, BCC)
I just feel like it’s a sword hanging over my head. I guess because you are always keeping an
eye on things, it’s always there—it’s like an undercurrent in your life. (MacLoone 2013. p1106,
M)
The risk of me having another occurrence of melanoma is probably greater ….and that is
frightening. (McLoone 2013. P1997, M)
Many patients reported engaging more proactively in risk minimisation by usingsun avoidance measures and undertaking regular skin self-examination. Somepatients felt they had insufficient knowledge/information on how to self-monitorand what to look for.
Because to be quite honest I have had no literature about my melanoma, I have asked for
booklets but there’s never been any in the hospital and none’s been sent out to me (Hall
2014.p1668, M)
I wasn’t really given any advice on checking it at all. You know, I was just told that it was sun
damage on my face and on my nose but I wasn’t given any advice on how to check it. I mean
I know, I've read up a lot about it, so I know that I check and then if there’s things I can’t see
like my back, I get my husband to check, and I always check his regularly as well (Bath-
Hextall 2013. p8, BCC)
I am [checking], yes, but I’m not too sure what to look for.... Now if I see anything that’s not,
I’ll be, instead of waiting I shall be straight to the doctor’s and see what it is. (Bath-Hextall
2013. p7, KC)
The presentation format of this information was limited and not always helpful: About my
recurrence, they gave me percentages; anyway it was kind of alarming. Wasn’t sure what it
meant. (Loescher 2009. p303, M)
Um, the only change in lifestyle that I’ve done, as a result of the cancers, is I am much more
aware of being in the sun without some sort of protection. (Steenrod 2015. p194, non-
advanced BCC)For some patients, their experience led to an increased concern for family andcommunity members about their risks of skin cancer. In some cases, patientswould actively educate others and encourage treatment seeking and preventivemeasures.
One or two people I have spoken to and I’ve said, I did say look out for dubious looking spots
and things that won’t go away with ointments and things. (Bath-Hextall 2013. p7, KC)
Some participants perceived that family members had frank discussions about melanoma
prevention and detection activities. For example, family members persistently reminded each
other about sun safety in discussions of sun avoidance and shielding (e.g., sunscreen
application and use of sun-protective clothing). (Loescher 2009. p6, M)
Synthesised finding 4: Satisfaction with skin cancer care and confidence in
healthcare providersSatisfaction with skin cancer care is influenced by the perceived competence ofthe relevant healthcare providers and by the structure and organisation ofservice provision. Health professionals can assist patients during treatment andbeyond through clear and open communication, a caring approach and byproviding support for positive coping strategies.Some melanoma patients found the clinical settings unsuitable (e.g. overcrowdedor lacking in privacy), which impacted on how they interacted with theirhealthcare providers. Some patients were particularly unhappy about longwaiting times and limited consultation periods which hindered their ability toseek reassurance and information. In some settings, patients objected tofrequent follow-up visits as these disrupted everyday life.
[Describing a follow-up at hospital]. “At ……… it was bedlam, about 30 people in the waiting
room. It just seemed like a cattle market, you know, can you understand what I mean. Every
few minutes one was coming in and one was coming out.” Patient 10. […] “It’s pretty drab and
oppressive really. It doesn’t seem to have had a lick of paint since the seventies.” (Murchie
2010. p230, M)Patients were satisfied with providers who they perceived to be clinicallyknowledgeable and who treated them in a holistic manner with compassion andempathy. Where either of these facets was missing, care was perceived as sub-optimal.
[A patient whose Dermatologist had misdiagnosed the cancer]: ‘And there’s a lot of ignorance
around. Doctor says something, you think that’s it. I was very ignorant with that ﬁrst 
melanoma... (Oliveria 2013. p111, M)
“I don’t want the comments anymore, if I have another medical student who says, ‘Oh my
gosh, you really had five melanomas. ’I don’t want that anymore.” (Loescher 2009. p304, M)
Melanoma patients in a GP-led follow up study had less confidence in the GP as compared to
their hospital doctor and needed reassurance that they had undergone additional training.
However they did feel that they were getting more detailed and comprehensive consultations
as compared with the hospital appointments.
“When I went to her she spoke about having all the information, but she kept having to look
up bits of paper. I just got the impression she wasn’t 100% clued up about what was going
on. At the hospital I felt they knew these things as a matter of course.” (Murchie 2010. p230,
M)
“He takes that bit more time. I was given a top to toe examination on both occasions and I
felt I was getting a better return from him than I got from the hospital” (Murchie 2010. p229,
M)
Discussion and recommendations
The previous systematic review in 2010 10, highlighted the need for furtherresearch into the needs and experiences of skin cancer patients. Six years later afurther 12 studies have been published, however only two of these studiesexclusively considered keratinocyte carcinoma 21, 30. Despite the high incidencerates of keratinocyte carcinoma worldwide 1, very few studies have directlyinvestigated the psychosocial effects of this cancer and its treatment.The synthesized findings from this review provide new insights into thecomplexities and challenges of a patient who is diagnosed and treated for a skincancer however still very few studies focus on the most common cancer inhumans (keratinocyte carcinoma) and therefore an area for further research.At diagnosis, despite the fact that keratinocyte carcinomas and melanomas canhave very different prognoses, health professionals need to be sensitive to, andacknowledge, that having a diagnosis of any type of skin cancer often causesdistress. The review shows that all patients require support and understanding,together with tailored information. Studies of other cancer types report similarconclusions 36.The time around treatment and immediately afterwards can be very different forskin cancer patients depending upon their treatment, type of cancer and stage.This is a time where there is a requirement for clear information that is tailoredto the needs of the individual. Patients also need to be followed up by healthcareprofessionals who are not only clinically knowledgeable but show compassionand an understanding of the patient’s psychosocial needs.The review has shown that the follow up period can be experienced as a time ofconsiderable uncertainty and fear especially around prognosis and recurrence.These findings are consistent with issues identified in a systematic review thatlooked at the unmet supportive needs of people with cancer 37 and other studiesin other cancer types 38, 39.Patients require clear supportive information about surveillance and riskmanagement and this should include being able to identify skin changes, preventand manage further risk - not just for themselves but also their family.Knowledge about recognising signs of skin cancer is particularly important since44% of patients with a Keratinocyte Carcinoma will develop additional lesionswithin 3 years 40 and there is a 2.8% risk of developing a second melanoma afterfive years and a 3.6% risk after 10 years 41. Other quantitative studies have alsoshown that patients with keratinocyte carcinoma experience anxiety and worryabout future skin cancers 42, and have unmet needs regarding health system andinformation matters 8.
Level of confidence in the synthesised findingsThe overall methodological quality of the included studies was good, althoughthere was general poor reflexivity. Giving an overall score for the level ofconfidence in qualitative review findings is a relatively new development 43, 19,and draws upon the concepts of dependability (established using a set of critical
appraisal questions) and credibility (ranked according to the ‘goodness of fit’between the author’s interpretation and the original data). Therefore there willalways remain an element of subjectivity in assigning a level of credibility. Theincluded findings were mainly unequivocal, with fewer equivocal and nounsupported findings. The overall dependability and credibility of all synthesisedfindings were therefore downgraded by 1 level and the overall ConQual scorewas medium (Table 6).
Limitations:The review included 14 studies representing only 4 countries and therefore caremust be taken in generalising the results of this review to other countries. Inparticular the category ‘financial concerns and consequences’ only applies to theUSA and other countries with similar health systems.Search strategies for qualitative research are less developed compared toquantitative research and therefore the main limitation of this review is that thesearch strategy may not have captured all relevant qualitative studies 15.
ConclusionThis review has shown that, for many patients, having a skin cancer marks thestart of a journey. The review shows that specific needs and experiences willvary at each stage depending upon the type of cancer and severity. Crucially, thereview highlights how this journey does not end for patients with the cessationof treatment, but continues into an uncertain future requiring ongoing self-monitoring and often accompanied by fear and uncertainly around theidentification of new skin abnormalities.
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Table 1: Characteristics of included studies
Study &
Setting
Methods Participants Data analysis Phenomenon of interest
Bath-Hextall
(2013)
UK
Mixed methods study
Semi structured interviews
conducted over the telephone
with the exception of one face
to face interview
Interviews were conducted at 4
time points: diagnosis,
treatment, 8 weeks post
treatment and one year post
diagnosis
77 Participants (BCC and SCC) attending a
skin cancer clinic and with a new clinical
diagnosis of non-melanoma skin cancer. 15
participants were interviewed
Mean age 70 years (range 35-89)
Thematic analysis The needs, experiences and
knowledge of individuals with Non
Melanoma Skin Cancer (NMSC) from
diagnosis up until one year
Loescher
(2009)
USA (two
papers)
In-depth interviews separately
for melanoma patients and for
family members
11 participants with newly diagnosed
melanoma and with a family history of
melanoma recruited from the Cutaneous
Oncology Program (COP)
Age range (18-65 years)
Content analysis High-risk family members’
perceptions of healthcare provider
communication regarding risk and
risk modifying behaviours and
recommendations for enhancing
such communication
McLoone
(2013)
Australia (2
papers)
Semi-structured telephone
interviews of participants who
were at the follow up stage
20 high risk melanoma participants (9 male, 11
female recruited via the clinical database of the
High Risk Clinic (HRC) and who had attended
a minimum of three clinical consultation at the
HRC. High risk defined as multiple diagnoses
of primary invasive melanoma, or diagnosis of
one primary invasive melanoma in addition to
dysplastic nevus syndrome.
Participants on current active treatment for
locally advanced or metastatic melanoma were
excluded.
Mean age 57.6 years
Content analysis Satisfaction with clinical care among
individuals at high risk of developing
melanoma, while receiving best
practice follow-up care at a highly
specialized melanoma clinic
Murchie
(2010)
UK (Scotland)
Semi-structured telephone
interviews
18 melanoma participants
(10 male, 8 female) whose melanoma had
been surgically excised and were recurrence
free. Age range (24-82) years
Thematic analysis Practical experiences and feelings of
people with cutaneous malignant
melanoma about receiving structured
melanoma follow-up from their
general practitioner (GP) as an
alternative to traditional hospital-
based follow-up
Oliveria
(2013)
USA
8 focus groups Follow-up (1-10 years) of 48 melanoma
survivors (18 male, 30 female) attending the
memorial Sloan-Kettering Cancer and who had
invasive primary cutaneous melanoma stages
I-III. Age range (26-90) years
Thematic text
analysis
Experiences of melanoma survivors
regarding sun protection, surveillance
practices, psychosocial and family
concerns
Stamataki
(2015)
UK
Semi-structured interviews
in a location convenient to the
participants, in the study
hospital or in the patient’s
home
15 participants (8 females, 7 males) with
melanoma stages I to III and between 3
months to 5 years post diagnosis. Recruited
from large specialist cancer referral and
research centre. Age range (27-78) years
Thematic analysis Impact of melanoma diagnosis on the
supportive care needs of patients
with cutaneous melanoma
Stothers
(2015)
UK
Semi-structured interviews
conducted in a quiet room
when they were attending for
outpatient review
appointments
6 melanoma participants (2 male, 4 females)
diagnosed with nodal relapse of melanoma
and at least 4 weeks post-block dissection
of neck, axilla or groin for nodal relapse of
melanoma within the last two years. Recruited
from consultant plastic surgeons clinic. Age
range (31-60) years
Thematic analysis Patients’ information and support
needs when diagnosed with nodal
relapse of melanoma and their
experiences of the changing nature
of coping with nodal relapse
Taylor (2009)
UK (Wales)
Semi-structured interviews 10 males presenting to dermatology
department with having been referred by GP
for suspect melanoma
Content analysis Men’s perception of malignant
melanoma
Winterbottom
(2004)
UK
Semi-structured interviews
conducted in a consulting
room at the dermatology
centre
16 participants at different stages in the
disease trajectory (5 malignant melanoma, 4
squamous and 7 basal cell carcinoma),
recruited from a dermatology clinic.
Mean age 63.8 years (34-90 range)
Interviews took place 3-48 months post
diagnosis (mean 8 months and 1 week)
Thematic content
analysis
Experience of diagnosis and
treatment of skin cancer
Tan (2014)
Australia
Semi-structured interviews 19 participants diagnosed with stage III
melanoma and free of disease recurrence at
their most recent follow-up (10 female, 9 male)
attending Melanoma Institute of Australia, a
multidisciplinary melanoma research and
treatment center. Mean age 58 years, SD 14
(range 30-82)
Thematic analysis Psychosocial impacts experienced by
stage III melanoma patients (and
caregivers) throughout the course of
the disease, and the coping
responses they utilised in an attempt
to promote psychosocial adjustment
Moore (1996)
UK
Semi-structured in-depth
interviews
7 patients melanoma (3 men and 4 women)
attending a plastic surgery outpatient
department in a district teaching hospital.
Age range 34-76 years
Content analysis Information needs of patients who
are diagnosed with malignant
melanoma and treated on an
outpatient basis
Clarke (2006)
UK
Semi-structured interviews
during treatment and follow-up
11 melanoma patients (6 men and 5 women)
receiving treatment at a large teaching
hospital, UK, for a first relapse of malignant
melanoma
Thematic analysis Perceptions of available support
services, preferences for source and
type of support, and satisfaction with
information and emotional support
provided by staff
Steenrod
(2015)
USA
Cross-sectional study using
semi-structured telephone
interviews
34 patient interviews were conducted on newly
diagnosed or recurrent BCC patients. Group 1
comprised of 11 patients with superficial
subtype and 2 patients with nodular subtype
BCC. Group 2 comprised 12 patients with
metastatic BCC and 9 patients with locally
advanced BCC.
Patients were recruited from three clinical sites
in the USA over a 10-month period.
Content analysis Symptoms, impact of symptoms, and
the health-related quality of life
(HRQL) impact of BCC on the daily
lives of patients across different
stages of the disease
To compare descriptively the
experiences, symptoms, and
HRQL impact of patients with non-
advanced BCC with those of patients
with locally advanced or metastatic
disease
Hall (2014)
UK (Scotland)
Semi-structured interviews
were conducted, either face to
face or on the telephone
21 participants (37-83) receiving structured
follow up for melanoma
Thematic analysis Views on the use of digital
technology during follow-up and
identify barriers or facilitators
1Table 2. JBI-QARI critical appraisal for included studies
Studies Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Dep
Bath-Hextall 2013 U Y Y Y Y N N Y Y Y
Hall 2014 U Y Y Y Y N N Y Y Y
Loiselle 2013 U Y Y Y Y N N Y Y Y
McLoone 2013 U Y Y Y Y N N Y Y Y
Loescher 2009 – same study
as Loescher 2009 (a)
Y Y Y Y Y N N Y Y Y
Murchie 2010 U Y Y Y Y N N Y Y Y
Oliveria 2013 U Y Y Y Y N N Y Y Y
Stamataki 2015 U Y Y Y Y N N Y Y Y
Stothers 2015 U Y Y Y Y Y N Y Y Y
Taylor 2009 U Y Y Y Y N N Y Y Y
Winterbottom 2004 U Y Y Y Y N N Y Y Y
McLoone 2012 U Y Y Y Y N N Y Y Y
Tan 2014 U Y Y Y Y N N Y Y Y
Moore 1996 U Y Y Y Y Y Y Y Y Y
Clarke, S. A., et al. (2006) U Y Y Y Y N N Y Y Y
Steenrod, A. W., et al. (2015) U Y Y Y Y N N Y Y Y
Criteria (Y=yes, N=no, U=unclear, Dep=Dependability grade)
Q2,Q3,Q4,Q6 and Q7 are questions for judging dependability
Arrow horizontal = the findings remain unchanged
Arrow down = move down one level
Table 3. Synthesized findings and categories
Synthesized Finding Categories
Synthesised finding 1: The time of diagnosis
Diagnosis is a time of shock and distress, where patients have significant support and
information needs irrespective of the type of skin cancer. For many patients, this diagnosis can
come as a severe shock, especially for those who believe their symptoms are relatively mild
and therefore nothing to worry about.
 Shock
 Fear and distress
 Needing emotional support
 Needing information and clear communication
Synthesised finding 2: The time around treatment and immediately afterwards
For the time around treatment and afterwards, the experience of having skin cancer varies
depending upon the type, stage and treatment. The impact of a skin cancer diagnosis can have
significant emotional, physical, social and financial impact, some of which can be long lasting,
and for which patients and their families may need support. Patients cope with their
experiences in a variety of ways.
 An emotional journey
 Physical consequences
 Changes to body image
 Social and relational changes and impacts
 Financial concerns and consequences
 Coping
Synthesised finding 3: The time after treatment and the follow up period
Skin cancer survivors and their families may have ongoing support, information and risk
management needs. The survivorship phase can be a period of liminality, characterised by fear
and uncertainty, related to the possible, yet uncertain, risk of skin cancer recurrence. Patients’
care and information needs during skin cancer survivorship include the need for being able to
identify, prevent and manage further risk for themselves and for the family.
 Being in limbo: on-going fear and uncertainty
 Self-monitoring
 Understanding and communicating risk
Synthesised finding 4: Satisfaction with skin cancer care and confidence in healthcare
providers
Satisfaction with skin cancer care is influenced by the perceived competence of the relevant
healthcare providers and by the structure and organisation of service provision. Health
professionals can assist patients during treatment and beyond through clear and open
communication, a caring approach and by providing support for positive coping strategies.
 Structure and follow up services
 Competence, clinical knowledge and compassion
Table 4. Synthesized findings and categories
Synthesized Finding Categories
Synthesised finding 1: The time of diagnosis
Diagnosis is a time of shock and distress, where patients have significant support and
information needs irrespective of the type of skin cancer. For many patients, this diagnosis can
come as a severe shock, especially for those who believe their symptoms are relatively mild
and therefore nothing to worry about.
 Shock
 Fear and distress
 Needing emotional support
 Needing information and clear communication
Synthesised finding 2: The time around treatment and immediately afterwards
For the time around treatment and afterwards, the experience of having skin cancer varies
depending upon the type, stage and treatment. The impact of a skin cancer diagnosis can have
significant emotional, physical, social and financial impact, some of which can be long lasting,
and for which patients and their families may need support. Patients cope with their
experiences in a variety of ways.
 An emotional journey
 Physical consequences
 Changes to body image
 Social and relational changes and impacts
 Financial concerns and consequences
 Coping
Synthesised finding 3: The time after treatment and the follow up period
Skin cancer survivors and their families may have ongoing support, information and risk
management needs. The survivorship phase can be a period of liminality, characterised by fear
and uncertainty, related to the possible, yet uncertain, risk of skin cancer recurrence. Patients’
care and information needs during skin cancer survivorship include the need for being able to
identify, prevent and manage further risk for themselves and for the family.
 Being in limbo: on-going fear and uncertainty
 Self-monitoring
 Understanding and communicating risk
Synthesised finding 4: Satisfaction with skin cancer care and confidence in healthcare
providers
Satisfaction with skin cancer care is influenced by the perceived competence of the relevant
healthcare providers and by the structure and organisation of service provision. Health
professionals can assist patients during treatment and beyond through clear and open
communication, a caring approach and by providing support for positive coping strategies.
 Structure and follow up services
 Competence, clinical knowledge and compassion
Table 5. CATEGORIES AND REPRESENTATIVE QUOTES
Categories Representative quotes
Shock I was so upset about the diagnosis that I don’t think much information would have penetrated
because I was too focused on thinking I’ve got cancer because you seem to, I went into a, like a
shocked of my own and switched off I think. (Moore 1996. p60, M)
I went very quiet for the first fortnight afterwards… of course I was panicking for 14 days…and
then when he turned around and said you have got it all (the Malignant Melanoma was
completely excised) but we are going to take a precaution now (and excise a further 1–2cm) and
that was a relief, that first fortnight, every time I had nothing to do I would sit down and start
thinking, what if. (Taylor 2009. p33, M)
…extremely upset, actually, and quite shocked, because I was told that it was very unlikely that it
was anything…so I was shocked, to say the least. (Winterbottom 2004. p230, M)
Um..obviously when they told me it was cancer, the big ‘C’ word, it was scary …but I was still
quite calm, because I was told that it was 0.6 mm. And if it’s over 1 mm, that’s when it’s got the
potential to spread. So I was still quite calm and I thought, ‘Oh well, you know, we’ve caught it
early enough, I’m not too worried. (Winterbottom 2004. p230, M)
…the consultant just had a look at it and said, ‘I think it’s a … ‘ and I couldn’t even remember the
term after I got out of the hospital, but he said , ‘I think it’s a basal cell carcinoma’. Now the only
thing I know about the word carcinoma is that it’s linked to cancer. And having shortly before lost
my brother to cancer, I must admit I did initially go into a bit of a flat spin (panic)… (Winterbottom
2004, p229, BCC)
It’s very confusing ... You’re going from doctor to doctor ... They’re all saying things at you ... and
you’re just sitting there going ‘I’ve got cancer’ ... you are definitely not taking anything in. (Tan
2014. p11, M stage III)
You know, to the person who has actually got it it’s not relatively minor… it’s that big C word
again, and while it’s there it can spread. But that’s a personal feeling of mine and I don't know
how many people are diagnosed with this type of thing yearly but I bet most people feel the
same. (Bath-Hextall 2013. p6, KC)
Physically I was aware of the signs of recurrence and psychologically I found it easier to cope, as
opposed to the initial diagnosis which was a major shock (Stothers 2015. P34, M with nodal
relapse)
Fear and distress Um, there are one or two things that I have thought about, um, perhaps I’ve been lucky, in my
opinion, it hasn’t been very long, I don’t know, but it’s the initial wait, the first, when you see the
doctor until you have the first operation, the waiting and not knowing, you know…that’s the worst
part about it, it is the waiting and not knowing. (Moore 1996. p62, M)
Over the fortnight while I was waiting for the results I had some really bad days when I thought
gosh I’m not going to be here in six months’ time. (Moore 1996. p62, M)
Needing emotional support
(Emotional needs at
diagnosis)
Immediately around the time of being biopsied and finding the results, I’d say that for me is pretty
severe. Now I’m just sort of waiting to get through the process and then it’s going to be very
stressful the day of the surgery and the day after for sure … (Steenrod 2015, p193, non-
advanced BCC)
…and then, I can’t say I’m feeling down today or whatever, I’m going to [cancer hospital] on
Monday, I feel a bit crap today and all that. But you can’t, I mean, if you knew somebody on the
phone or you were going to [cancer hospital] and you could have half and hour….. But there’s
nothing, you’re just out on a limb really. Even though it’s a cancer, there’s no actual help type
thing (Stamataki 2015, M stage IIIc)
There’re just so many people that don’t understand how dangerous [melanomas] are. Like I’ve
had many people say, “Oh you’ve just had a mole removed,” and I’m like, “It’s actually cancer,
believe it or not.” So yeah, there’s a wrong perception from most people. The actual depth of
what one is I think is missed. (McLoone 2012. pp1108-1109, M)
I definitely think there’s something in positive language regardless of whether it’s the right think to
do or whether people see you coming back with cancer. There is definitely something about
giving somebody a positive message. Albeit for that time (Stothers. P35, Melanoma relapse)
Needing information and
clear communication
Maybe a little bit more information about what the scar would feel like and look like …………’
(Bath-Hextall 2013. p7, BCC)
…but it’s all these stages and we didn’t have a clue…but you couldn’t ask anybody, you know,
go back to them and say; cause you don’t keep like to say ‘well, I’ve been today to the thing
[hospital] and they said stage three’. Well, what does stage three mean? (Stamataki 2015. p785,
M stage IIIc)
When I go to the clinic I don’t seem to be, I don’t seem to be picking up just what the situation is,
you know, what I can expect for the future, what will the next stage be? What will be the next
thing to happen? (Stamataki 2015. p785, M)
…there was [consultants name] gave me a little thing about the thing to start off with. You know,
on the very first day there was a pack of things and sor t of nice pictures and good information
and so on….but it was day one, here’s your package , erm, and that’s everything finished…there
was o further information added in, after the op and things like that.. Yes, they talked a little bit
about it but if someone’s telling you you’re going to have a fairly major operation, not everything
goes in… (Stamataki 2015, p786, M)
He is probably a brilliant surgeon but he was certainly no communicator …we were both scared
to ask questions because he answered them with one word (Tan 2014. P12, M)
An emotional journey Nobody rings me up and says ‘How are you going?’, ‘Are you feeling all right?’ I suppose they’ve
got so many they can’t remember everybody.” (Tan 2014. p15, M stage)
I had no idea how to put [the stocking] on. I had no understanding of lymphedema. (Tan 2014.
p12, stage III M)
Oh look, I couldn’t care less about scarring. I would rather a scar than, you know, be dead.
(MacLoone 2012. p1106, M)
When I don’t think I’m going to be out and I end up having to be out, you get stressed. Like I’m
outside for a half hour and I’m like, “I’ve got to get out of the sun. I don’t have anything on.
(Oliveria 2013. p111, M)
I’d tend to find the sadness in everything ... I did have a few times there where I was so
depressed I probably did go a little bit suicidal ... thoughts would be running through your mind, ‘If
I’m going to die, just let it happen really quickly rather than dragging on. (Tan 2014. p17, M stage
III)
I was just snapping at everyone because I was so frustrated I couldn’t get up and do it myself ...
it was very, very frustrating, just not being able to do a normal, everyday, simple thing, even
down to bathing. (Tan 2014. pp16-17, M stage III)
I’d say stress related to the cancer is the most bothersome and biggest issue…there’s an
unknown component whether it’s going to heal or not and whether it’s going to leave physical
scars or not. (Steenrod 2015. p193, non-advanced BCC)
Probably – at this point, probably the stress of the unknown because I know the itching will go
away and the redness will go away. (Steenrod 2015, p 193, locally advanced and/or metastatic
BCC)
Uh, I’m tired of having my body cut. I mean, you could say it’s at times mildly depressing
.(Steenrod 2015, p194, non-advanced BCC)
Physical consequences …‘I have struggled to move away from that time in hospital. I found it very difficult. I don’t think in
any way I was prepared for what it would do physically. The seriousness of it and the debilitating
effect of the surgery was far more than I thought it was going to be’ (Stothers 2015. p34-35, M)
I’m an active person, I play tennis and I surf, I’m always swinging a golf club … I was without my
arm for quite a while and I didn’t know if it was going to come back, so it was pretty emotionally
traumatising. (Tan 2014. pp12-13, M stage III)
“I can’t walk the dog ... I don’t bend over in the garden for a long time because I can't get back
up ... I can't have hot water on my legs so during the day I’ve got to shave [them] outside ... it’s
about the simple things in life that you take for granted.” (Tan 2014. pp14-15, M stage III)
Well, I’m stuck inside, like I said. I mean, I can jump in the car and go to the store and stuff. But
I’m limited to doing normal things of going outside, maybe going to a, to a baseball game, or
going to the park and just going…for a walk. I can’t do any of those things. (Steenrod 2015.
p194, locally advanced and /or metastatic BCC)
Itching and, uh, itching and burning because that causes, when I rub that it causes it to bleed.
You know, even if you rub on the side of it or something, uh, then the scab comes off. So the
itching is what triggers it. (Steenrod 2015. p193, locally advanced and /or metastatic BCC)
I’d say stress related to the cancer is the most bothersome and biggest issue….there’s an
unknown component whether it’s going to heal or not and whether it’s going to leave physical
scars or not. ( Steenrod 2015, p193, non-advanced BCC)
Changes to body image I was really shocked at what the operation had done. It was really disfiguring ... When you’re
disfigured in any way it takes a toll psychologically. (Tan 2014. p17, M stage III)
Well I don’t know why I thought they would fill it in [the scar]…when I had the operation I was in
bed…and they came to the great unveiling…she took the dressing off and they were all ‘oh great’
and all this that and the other…and I’m just looking…the nurse on the ward, she says to me ‘are
you alright?’ I went ‘well, to be truthful…they’re all congratulating saying how great it is and all I
can see is a dirty great crater’. She said ‘did you not expect that?’ I said ‘no, I didn’t’…I mean I’m
not that bothered because the cancer’s gone but it was a shock at the time. (Stamataki 2015.
p783, M)
I just don’t know, and I just feel, like probably physical appearance is flawed a little bit… so I feel
a little bit different about myself or how people see me, and it’s daft because I know everybody
says ‘you’re just the same’… and I am the same person…maybe I feel I’ve not met anybody or,
you know, they might find me sort of less attractive because of this thing (Stamataki 2015. p783,
M)
Oh look, I couldn’t care less about scarring. I would rather a scar than, you know, be dead.
(MacLoone 2012. p1108, M)
Well, I don’t, I don’t like it when people stare at me. Um, it makes me a little bit uneasy;
especially the little children. That bothers me. (Steenrod 2015. p194, locally advanced and /or
metastatic BCC)
I was a little anxious because I didn’t quite know what I was going to look like when I was
finished (Bath-Hextall 2013.p7, BCC)
Well, I wear a hat and the wig because after all these surgeries I- I have no hair, it’s all scar
tissue and [sigh] I think my mind has shut down ( Steenrod 2015. p194, non-advanced BCC)
Social and relational
changes and impacts
Well I’ve been married to the same person for 42 years, and I love him dearly, but he didn’t do
well with my diagnosis, which was two years ago. And it was a stage II, and it was a big—it was
a fairly big deal. But for some reason he became sick when I got the diagnosis. It was almost as
though I was getting more attention than he was, and this became a problem just because I sort
of—I guess I’m sort of an insular person, and when this happened I sort of turned inward, and
you’re trying to steel yourself and get through this, and you just don’t want to deal with—I don’t
want to deal with other people and their problems. I need to focus on this. And it’s a selﬁsh thing 
for me, I know that, but I couldn’t deal with him. I never took him with me to the doctor because
the ﬁrst time I did I came out to the waiting room and there he is and he says, “Oh, I feel awful.” 
Wait a minute, you know? I’m the guy with cancer, and you feel awful? So this was a problem for
probably the ﬁrst year. (Oliveria 2013. p110, M stages I-III) 
It’s (hearing about increase likelihood of getting a new melanoma if you get pregnant) a
disappointment. He (doctor) said there are studies showing that you can—so you’re actually
taking a personal risk by getting pregnant, not to mention that then that’s a period of not being as
vigilant, because I can’t do some of the screens I was doing. So it’s sort of just hard to put at
odds having a family versus taking care of your own body.’ ‘I’m thirty-nine and between my age
and the impact of getting pregnant with hormonal levels on melanoma—I think one of the things
that’s impacted me most signiﬁcantly is that I’ve decided not to get pregnant. (Oliveria 2013. 
p111, (M stage I-III)
…But your managers, you know, like I’d go in and say ‘oh I’m really struggling at the minute, can
you take, I can’t do this, I need a bit of a, some weight taken off me at work’ and they’ll do it for a
short period of time while you’re in distress but then it’s soon back on you isn’t it? (Stamataki
2015. p784, M)
It puts a black cloud above [your life] ... my husband’s family is organising a family holiday next
April ... it’s very difficult to commit to that because I don’t have a clue what’s going to be going
on. (Tan 2014. p13, M stage III)
Yeah, I’m not as motivated, you know, I just I’m tired, uh, when you’re not sleeping you don’t
have that energy to go to go out there and, and do those things [hiking with dog or going
snowshoeing with friends]. I try to push myself too when I have a good days, but there’s been a
lot more bad days. (Steenrod 2015. p194, non-advanced BCC)
What it did do, I think, more than anything else, was to make me understand the effects, of the
impact it would have on other people in more serious cases (Winterbottom 2004. P231, M)
I don’t know if it’s leisure, but it’s basically all the yard wor. Back when they were open sores it
would stop [me from] meeting people-talking to people and basically staying in . (Steenrod 2015.
P194 locally advanced and /or metastatic BCC)
In terms of my life, I think it just made me focus down on the day to day and not be so over
whelmed with irritations at work…It’s just- it’s like it’s not important. The fact that I’m alive
another day is more important. (Oliveria 2013. P110, M stage III)
Financial concerns and
consequences
I mean and then what do you do if you can’t get health insurance? I’ll have to take a lousy job
that I don’t want to work at so that I’ll have health insurance. Yeah, that’s actually a huge fear for
me. (Oliveria 2013 p.111, (M stages I to III)
It (my melanoma diagnosis) really didn’t hit me until I went to apply for life insurance...it was the
life insurance that made it hit home and there was a difference—I have a history that affected my
life. (Oliveria 2013. p111, M stages I to III)
I wouldn't want to go in another trial because I'd have to be in Sydney every three weeks and it's
going to cost us 600 [dollars] every time we went ... and we just haven't got that money.” (Tan
2014. p13, M stage III)
Coping I’m still reasonably optimistic about the future. I am aware of how serious and life-threatening my
disease is but I don’t feel it’s a tragic situation. If you plan to die you will die so my view of it is
that I don’t plan to die. I have chosen to live and the feeling of normality is very important in lifting
you from a depressed feeling. (Stothers 2015. pp35-36, M with nodal relapse)
I know it’s not severe at all if you have it removed quickly. (McLoone 2012. p1106, M)
…this diabetes that I got is more worrying, „cos you don’t know what you can eat, what you can’t
eat… (Winterbottom 2004. p230, KC)
I have to say that I’m a Christian and I believe in healing, and so the whole thing wasn’t too much
of a problem. I won’t say I wasn’t concerned, but the faith kept me going and I knew that other
people were praying for me (Winterbottom 2004. p230, M)
There’s some things you don’t want to ask, some things you don’t want to know about ... you can
maintain a more positive outlook if you’ve got some kind of ignorance. (Tan 2014. p12, M stage I
to III)
Physically I was aware of the signs of recurrence and psychologically I found it easier to cope, as
opposed to the initial diagnosis which was a major ‘shock’ (Stothers) 2015. P34, nodal relapse of
melanoma)
I [thought] ‘I’ve just got to get up, I’ve got to start doing anything, I’m wallowing in self-pity here’ ...
So I got on to a personal trainer ... I just thought ‘I have to take control of this situation. (Tan
2014. p14, M stage I to III)
Family and friends have been absolutely amazing. My immediate family, I couldn’t have done it
without them ... my friends ... were absolutely amazing. They cooked and cleaned and
continually did it for nearly six months. (Tan 2014. pp18-19, M stage I to III)
My Christian faith definitely helped, that and the support of the church that we go to and knowing
that lots of people were praying for me, and knowing that God was in control. (Tan 2014. p20, M
stage I to III)
Being in limbo (Ongoing
fear and uncertainty )
You know, to the person who has actually got it it’s not relatively minor… it’s that big C word
again, and while it’s there it can spread. But that’s a personal feeling of mine and I don't know
how many people are diagnosed with this type of thing yearly but I bet most people feel the
same. (Bath-Hextall 2013. p6, KC)
Well, it’s just that, you know, I just hope that it’s all gone and that it’s not going to flare up again. I
mean, I'm touching wood, I don’t think it will do because I don’t think it was that sort of thing, but
there's bound to be doubts, small doubts, you know, even though people do try and reassure
you. But hopefully everything will be okay. (Bath-Hextall 2013. p7, BCC)
When I’d ﬁrst come for the quarterly check-ups or whatever, I’d feel a little tense, realizing that I 
could walk out of here with a different answer, or my life could change. (Oliveria 2013. p111, M)
The risk of me having another occurrence of melanoma is probably greater ….and that is
frightening. (McLoone 2013. P1997, M)
It’s weird cause you’re always looking for lumps or moles…you’re always conscious of it cause
you’re thinking is it another one? …I mean I am good at checking but it’s just there all the time it’s
like a curse on you type of thing. Yeah, even though you can’t; I mean I think I’d sooner have
treatment than just wait, you know like, cause it’s like, not a death sentence but it’s like, you’re
always worried that you are gonna find another lump but yeah, it never goes away, never…like
you’re in constant fear…And it never, never goes away and there’s like, there’s nothing you can
do or like any treatment you can do. You’re like waiting and waiting and waiting and that’s all
you’re doing (Stamataki 2015. p782, M]
I just feel like it’s a sword hanging over my head. I guess because you are always keeping an
eye on things, it’s always there—it’s like an undercurrent in your life (MacLoone 2013. p1106, M)
Each time I get another one I have a real sense of, “Oh God, here we go again,” and I wonder if
this is going to be the one that gets me. It’s not really a burden but it’s kind of like a shadow I
guess, and progressively it gets a little bit darker each time. . . . It’s going to be this constant, I
guess, worry or concern in my life. (MacLoone 2012. p1106, M)
Self-monitoring I am [checking], yes, but I’m not too sure what to look for.... Now if I see anything that’s not, I’ll
be, instead of waiting I shall be straight to the doctor’s and see what it is (Bath-Hextall 2013. p7,
BCC)
I wasn’t really given any advice on checking it at all. You know, I was just told that it was sun
damage on my face and on my nose but I wasn’t given any advice on how to check it. I mean I
know, I've read up a lot about it, so I know that I check and then if there’s things I can’t see like
my back, I get my husband to check, and I always check his regularly as well (Bath-Hextall
2013. p8, BCC)
I’m only too happy to examine myself. You know it’s my life on the line if I don’t bother so I’m very
happy to do it. (Murchie 2010. p229, M)
So what I should have done right from the beginning was, as soon as I saw something like that, if
they’re not real sure, why not just get it taken off? And why don’t you biopsy it or do something?
So that taught me to be real proactive. If somebody says, “Well, don’t worry about it,” I’ll tell you
what, if it bothers me, I’m not going to take that for an answer anymore. I’m going to say, “Do
something. I demand it. (Oliveria 2013. p110, M)
The presentation format of this information was limited and not always helpful: About my
recurrence, they gave me percentages; anyway it was kind of alarming. Wasn’t sure what it
meant” (Loescher 2009. p303, M)
‘I’m not a professional and I don’t trust that I will pick up on any change. It’s hard to work out
what was [already] there. I’ve got so many moles’. [Male participant] (MacLoone 2013. p1197, M)
Um, the only change in lifestyle that I’ve done, as a result of the cancers, is I am much more
aware of being in the sun without some sort of protection. (Steenrod 2015. p194, non advanced
BCC)
This last appointment was the first time that I was asked to. Nobody had mentioned that I should
be well I look at my moles, I keep an eye out because they are monitoring two others, I think
there’s nothing to do – it’s just that they are slightly different. But this was the first time somebody
had said to me that I should be checking under my arm for my lymph nodes. Nobody mentioned
that before (Hall 2014.P1665, M)
What my perception of what I should be looking for is obviously different from what one is
actually looking for, because the one on my wrist, I would think twice about it , and yet Dr X said,
‘that one’s going to have to go’ (Hall 2014.p1665, M)
No, no I just leave that to the experts. (Hall 2014.p1666,M)
But how can a lay person give a detailed explanation about melanoma, because I don’t know
what they look for. (Hall 2014.p1666,M)
Because to be quite honest I have had no literature about my melanoma, I have asked for
booklets but there’s never been any in the hospital and none’s been sent out to me (Hall
2014.p1668, M)
I suppose It’s more about having information about what melanoma means in relation to the
likelihood of me having it again. What should I be looking for? (Moore1996. P67, M)
Understanding and
communicating risk
One or two people I have spoken to and I’ve said, I did say look out for dubious looking spots
and things that won’t go away with ointments and things. (Bath-Hextall 2013. p7,BCC )
…it has raised awareness significantly in our family now, yeah…I’ve been into town today and
bought a moisturiser with SPF25 or something or other, so yeah. So I’ll wear that constantly now
rather than general moisturisers. (Bath-Hextall 2013. P 7, BCC)
Our friends all know that they can’t go anywhere outside with me unless they have put on
sunscreen. We [family] are responsible for spreading the word. We owe this to ourselves and to
others. (Loescher 2009. p6-7, M)
…as I say, certain members of my family used to have various bits and pieces like that and so I
wondered if to some extent these things were hereditary. (Winterbottom 2004. p229, BCC)
When I’m standing at an intersection I sort of find the shadow of a post,” believing that even the
smallest amount of sun exposure could trigger another melanoma. (MacLoone 2012. p1107, M)
Structure and follow up
services
At ……… it was bedlam, about 30 people in the waiting room. It just seemed like a cattle market,
you know, can you understand what I mean. Every few minutes one was coming in and one was
coming out.” Patient 10. […] “It’s pretty drab and oppressive really. It doesn’t seem to have had a
lick of paint since the seventies. (Murchie 2010. p230, M)
Parking is a nightmare; I’m always conscious of whether I’ve got enough money in the metre and
if they’re [i.e. the doctors] twenty minutes late, I could be late and I told them...if I get a parking
ﬁne I’m passing it onto you. (MacLoone 2013. p1998, M) 
…if I would have had to go home and waited I am not quite sure whether I would have made it
back. So I am glad that it was done on the day. (Winterbottom 2004. p231, M)
Competence, clinical
knowledge and
compassion
The good thing is the bad stuff’s gone and I’m not that vain, if you know what I mean. (Bath-
Hextall 2013. p6, BCC)
Some participants perceived passive and uncaring communication from providers: “I don’t want
the comments anymore, if I have another medical student who says, ‘Oh my gosh, you really had
five melanomas. ’I don’t want that anymore. (Loescher 2009. p304, M)
There’s a very valid lack of communication in the whole process, because lots of people are
intimidated and they won’t ask the doctor, “What did you say, what does this mean, what can I do
to correct this? (Loescher 2009. p304, M)
The main disadvantage of GP-led follow-up was feeling less reassured, or having less
confidence in their GP than in the hospital specialist. There was remarkable agreement amongst
participants that in order for patients to gain maximum reassurance during a GP-led follow-up
appointment, the GP needed to be friendly and known, have undergone extra training, appear
receptive to questions and familiar with the study protocol and working explicitly to a clear
structure. When some of these aspects were lacking, some patients reported feeling unhappy:
When I went to her she spoke about having all the information, but she kept having to look up
bits of paper. I just got the impression she wasn’t 100% clued up about what was going on. At
the hospital I felt they knew these things as a matter of course. (Murchie 2010. p230, M)
I feel more in control with this system. I know what I’m looking for and if there’s a problem or I’m
worried, I just need to pick up the phone and I can get seen the same day. I couldn’t do that
before. (Murchie 2010. p229, M)
The GP follow-up consultations were generally viewed as thorough, with many patients believing
that they were more detailed and comprehensive than consultations provided in hospital:
“He takes that bit more time. I was given a top to toe examination on both occasions and I felt I
was getting a better return from him than I got from the hospital” (Murchie 2010. p229, M)
Survivors believed it is important to ﬁnd a dermatologist whom they perceive to be competent—
some survivors had dermatologists who had missed their melanoma: ‘And there’s a lot of
ignorance around. Doctor says something, you think that’s it. I was very ignorant with that ﬁrst 
melanoma... (Oliveria 2013. p111, M)
…it’s almost a case of ‘right, turn, right, on the bed let’s look at your leg. Oh, that’s fine’ you
know, poke, poke, poke in the groin for any…swelling of the lymph nodes and ‘okay, you’re fine,
come back in 3 months (Stamataki 2015. p786, M)
I definitely think there’s something in positive language regardless of whether it’s the right thing
to do or whether people see you coming back with cancer. There is definitely something about
giving somebody a positive message. Albeit for that time (Stothers 2015. p35, M nodal relapse).
The emotional side of things is not taken into account somehow. Even when you're on the
treatment, it's "how are you feeling?" they're all physical symptoms of how you're feeling rather
than, "is it getting you down emotionally? How are you dealing with it? (Clarke 2006. p69, M
relapsed)
I'm not the sort of person who goes into a great deal of discussion about how I feel emotionally.
To me, I just want to come and get out as quickly as possible. So, yeah, I'm sure the support is
there if I want it, but I don't particularly need it (Clarke 2006. p69, M relapsed)

Table 6. ConQual summary of findings
Systematic review title: The needs and experiences of people with a diagnosis of skin cancer
Population: Adults (18 years and above) with skin cancer
Phenomena of interest: Needs and experiences
Context: All countries, all health care settings
Synthesized findings Dependability
rating
Comment Credibility
rating
Comment ConQual
rating
Comment
Diagnosis is a time of shock and distress
where patients have significant support and
information needs
Downgraded one
level. All primary
papers had clear
articulation and fit of
the methodology and
methods employed,
but the majority had
poor reflexivity
Downgraded one
level due to a mix
of unequivocal
and equivocal
findings
Moderate The overall
methodological quality is
good although there was
general poor reflexivity.
The included findings
were mainly unequivocal,
with fewer equivocal and
no unsupported findings
The experience of having skin cancer varies
depending upon the type, stage and
treatment. The impact of a skin cancer
diagnosis can have significant emotional,
physical, social and financial impact, some of
which can be long lasting, and for which
patients and their families may need support.
Patients cope with their experiences in a
variety of ways
Downgraded one
level. All papers had
clear articulation and
fit of the methodology
and methods
employed, but the
majority had poor
reflexivity
Downgraded one
level due to a mix
of unequivocal
and equivocal
findings
Moderate The overall
methodological quality is
good although there was
general poor reflexivity.
The included findings
were mainly unequivocal,
with fewer equivocal and
no unsupported findings
Skin cancer survivors and their families may
have ongoing support, information and risk
management needs
Downgraded one
level. All papers had
clear articulation and
fit of the methodology
and methods
employed, but the
majority had poor
reflexivity
Downgraded one
level due to a mix
of unequivocal
and equivocal
findings
Moderate The overall
methodological quality is
good although there was
general poor reflexivity.
The included findings
were mainly unequivocal,
with fewer equivocal and
no unsupported findings
Satisfaction with skin cancer care is
influenced by the perceived competence of
the relevant healthcare providers and by the
Downgraded one
level. All papers had
clear articulation and
Downgraded one
level due to a mix
of unequivocal
Moderate The overall
methodological quality is
good although there was
structure of service provision. Health
professionals can assist patients during
treatment and beyond through clear and
open communication, a caring approach and
by providing support for positive coping
strategies
fit of the methodology
and methods
employed, but the
majority had poor
reflexivity
and equivocal
findings
general poor reflexivity.
The included findings
were mainly unequivocal,
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no unsupported findings
Table 7. Search strategy for MEDLINE on Ovid
1 (melanoma adj1 skin).mp. [mp=title, abstract, original title, name of substance word, subject heading word, keyword
heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier]
2 (non-melanoma adj1 skin).mp. [mp=title, abstract, original title, name of substance word, subject heading word,
keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique
identifier]
3 (non adj1 melanoma adj1 skin).mp. [mp=title, abstract, original title, name of substance word, subject heading word,
keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique
identifier]
4 (skin adj1 cancer).mp. [mp=title, abstract, original title, name of substance word, subject heading word, keyword
heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier]
5 (basal adj1 cell adj1 carcinoma).mp. [mp=title, abstract, original title, name of substance word, subject heading word,
keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique
identifier]
6 (rodent adj1 ulcer).mp. [mp=title, abstract, original title, name of substance word, subject heading word, keyword
heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier]
7 (squamous adj1 cell adj1 carcinoma).mp. [mp=title, abstract, original title, name of substance word, subject heading
word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique
identifier]
8 1 or 2 or 3 or 4 or 5 or 6 or 7
9 Carcinoma, Basal Cell/
10 Carcinoma, Squamous Cell/
11 9 or 10
12 8 or 11
13 needs.mp.
14 experiences.mp.
15 information.mp.
16 preference.mp.
17 13 or 14
18 15 or 16
19 12 and 17 and 18
